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ABSTRACT
Objective Urinary tract infections (UTIs) are common in 
primary care. The yield of urine cultures in patients with 
UTI symptoms can be considerably different between 
high- income and low- income settings. This study aimed 
to explore possible causes of negative urine cultures in 
patients presenting with symptoms of UTI to primary 
health clinics in Harare.
Design Cross- sectional study.
Setting Nine primary health clinics in Harare, Zimbabwe.
Participants Adults presenting with symptoms of UTIs 
between March and July 2020.
Primary outcome measures Urine samples underwent 
dipstick testing, microscopy, culture, and testing for 
sexually transmitted infections (STIs) using GeneXpert and 
for the presence of antibiotic residues using an antibiotic 
bioassay. The primary outcomes were the number and 
proportion of participants with evidence of STIs, prior 
antibiotic exposure, leucocyturia and UTIs.
Results The study included 425 participants with a 
median age of 37.3 years, of whom 275 (64.7%) were 
women. Leucocyturia was detected in 130 (30.6%, 
95% CI 26.2% to 35.2%) participants, and 96 (22.6%, 
95% CI 18.7% to 26.9%) had a positive urine culture 
for a uropathogen. Chlamydia trachomatis, Neisseria 
gonorrhoeae and Trichomonas vaginalis were detected in 
43/425 (10.1%, 95% CI 7.4% to 13.4%), 37/425 (8.7%, 
95% CI 6.2% to 11.8%) and 14/175 (8.0%, 95% CI 4.4% 
to 13.1%) participants, respectively. Overall, 89 (20.9%, 
95% CI 17.2% to 25.1%) participants reported either 
having taken prior antibiotics or having had a positive 
urine bioassay. In 170 (40.0%, 95% CI 35.3% to 44.8%) 
participants, all of the tests that were performed were 
negative.
Conclusions This study found a high prevalence of 
STIs and evidence of prior antimicrobial use as possible 
explanations for the low proportion of positive urine 
cultures.
INTRODUCTION
Urinary tract infections (UTIs) are a common 
reason for presentation to primary care with 
10% of adult women experiencing at least 
one episode per year.1 Dysuria, which is one 
of the most common symptoms suggestive of 
a UTI, is reported in 2%–5% of presentations 
in general practice.2 While dysuria and other 
urinary symptoms such as frequency and 
urgency may be attributed to acute bacterial 
cystitis, they are by no means specific.3 Symp-
toms can be due to a wide range of infec-
tious agents as well as to other non- infectious 
causes (table 1). In high- income settings, 
acute bacterial cystitis is the most common 
cause of UTI symptoms in women presenting 
to primary care.2 Thus, the symptom complex 
is treated empirically with antibiotics, and 
diagnostic tests are not deemed routinely 
necessary. Patients whose symptoms do not 
respond to first- line antibiotics are reassessed 
Strengths and limitations of this study
 ► This is the first study exploring the causes for neg-
ative urine cultures among adults presenting with 
urinary tract infection (UTI) symptoms to primary 
care in a low- income setting.
 ► Antibiotic exposure was assessed using two differ-
ent methods.
 ► Testing for sexually transmitted infections (STIs) was 
limited to three major pathogens, which may have 
led to an underestimation of the prevalence of STIs.
 ► The prevalence of STIs is not generalisable to all 
primary healthcare attendees, as the participants 
were enrolled if they reported the presence of UTI 
symptoms.
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for other diagnoses or infections with organisms resistant 
to first- line antibiotics.4
The prevalence of positive urine cultures in patients 
presenting with presumed UTIs varies widely across 
different settings. This is particularly true when 
comparing studies from high- income and low- income 
settings.2 5 Possible explanations include (1) differences 
in prevalence of other conditions causing similar symp-
toms, (2) unregulated access to antibiotics leading to 
partially treated infections or (3) differences in labora-
tory techniques affecting the limit of detection.
This study aimed to evaluate possible causes of negative 
urine cultures in patients presenting with symptoms of 
UTI to primary health clinics in Harare.
METHODS
Adults (aged 18 years and above) presenting with symp-
toms of UTIs to nine primary health clinics in Harare 
were enrolled into the Antimicrobial Resistance in Gram- 
negative Bacteria from Urinary Specimens (ARGUS) 
study. In Zimbabwe, primary health clinics are nurse- led 
and serve the population living in their catchment area. 
Patients accessing the acute medical services have to pay 
a user fee. Access to diagnostic tests is limited beyond 
HIV, tuberculosis and malaria. The eligibility criteria and 
enrolment procedures for the ARGUS study were previ-
ously described.6 Patients were included in the study if 
they presented with at least two symptoms suggestive of 
UTI (dysuria, urgency, frequency, suprapubic pain and/
or flank pain).
This is a cross- sectional study reporting on a subset of 
participants from the ARGUS study who were consecu-
tively enrolled between March and July 2020. Mid- stream 
urine samples were collected from study participants 
and underwent dipstick testing, microscopy and culture 
using conventional microbiology methods.6 Leucocy-
turia was considered to be present if the sample had ≥106 
white blood cells/L on microscopy or a positive dipstick 
for leucocytes. Antibacterial activity of urine indicating 
possible prior antibiotic exposure was ascertained using 
a urine bioassay. Briefly, 20 µL urine was inoculated on 
a 6 mm filter paper disc that was incubated on Mueller- 
Hinton agar and using Escherichia coli (ATCC25922) as an 
indicator organism.7 Antibacterial activity was considered 
to be present in the sample if a growth inhibition zone of 
any size around the disc was observed following incuba-
tion for 24 hours at 37°C.
Urine samples were tested for sexually transmitted 
infections (STIs), specifically Chlamydia trachomatis and 
Neisseria gonorrhoeae. For women only, urine samples were 
also tested for Trichomonas vaginalis. STI testing was done 
using the GeneXpert platform (Cepheid, Sunnyvale, Cali-
fornia, USA) according to the manufacturer’s instruc-
tions. Treatment for STIs was prescribed during the initial 
Table 1 Causes of symptoms with acute onset that may be suggestive of a urinary tract infection in adults
Category Specific cause

















Other infections Mycobacterium tuberculosis (urogenital)
Schistosoma haematobium
Inflammatory Dermatological Irritant or contact dermatitis
Stevens- Johnson syndrome
Non- infectious Foreign body (eg, stone)
Reactive arthritis with urethritis
Non- inflammatory Drug or food related Spermicides, topical hygiene products, drugs, certain foods
Traumatic Urogenital instrumentation/surgery
Horseback or bicycle riding
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visit by the clinic nurse according to routine practice 
following the Zimbabwean national guidelines8 and inde-
pendent of study procedures. Participants with positive 
tests were notified of their result and offered treatment 
for themselves and their partners if they were not treated 
on their initial appointment. To ascertain if symptoms 
had resolved, a follow- up phone call was conducted 28 
days postenrolment.
Statistical analysis
Data were analysed using Stata V.15. Categorical data were 
described using counts and percentages, and continuous 
data were described using medians and IQRs. Differences 
between categorical and continuous variables were evalu-
ated using the χ2 and Mann- Whitney U tests, respectively. 
The level of significance was set at a p value of ≤0.05.
Patient and public involvement
There was no patient and public involvement in the 
study design. Results from this study were disseminated 
to nurses working in the polyclinics from where the study 
participants were recruited in order to improve patient 
care.
RESULTS
The study included 425 participants with a median age of 
37.3 years (IQR 26.8–48.0), of whom 275 (64.7%) were 
women and 172 (40.5%) were HIV- positive. All samples 
were tested for the presence of leucocytes, underwent 
conventional urine culture and were tested for C. tracho-
matis and N. gonorrhoeae. Samples from 175 women were 
tested for T. vaginalis. Of 425 urine samples collected, 420 
were stored for the antibiotic bioassay; volume was insuf-
ficient for storage for the remaining 5 samples. In 255 
(60.0%) of the participants, at least one of the tests was 
positive, while in 170 (40.0%) participants, all of the tests 
that were performed were negative, and the cause of their 
symptoms could not be determined or suspected. Figure 1 
shows the distribution of positive test results (STI positive 
83 (19.6%), urine culture positive 96 (22.6%), leucocy-
turia 130 (30.6%) and prior antibiotics 89 (20.9%)). 
Haematuria was detected in two (0.5%) participants.
Urine cultures were positive in 96 (22.6%), negative 
in 314 (73.9%) and contaminated in 15 (3.5%) partici-
pants. A higher proportion of urine cultures were posi-
tive in women (n=73, 26.6%) compared with men (n=23, 
15.3%). Urine culture positivity was higher in participants 
with more recent symptom onset prior to presentation 
(58/225, 25.8% in those with a symptom onset of ≤7 days, 
vs 37/197, 18.8% for those with symptoms >7 days, 
p=0.086).
Overall, 83/425 (19.5%, 95% CI 15.9% to 23.6%) 
participants had an STI including 11 who also had a posi-
tive urine culture. The prevalence of C. trachomatis was 
43/425 (10.1%, 95% CI 7.4% to 13.4%); that of N. gonor-
rhoeae was 37/425 (8.7%, 95% CI 6.2% to 11.8%); and that 
of T. vaginalis was 14/175 (8.0%, 95% CI 4.4% to 13.1%). 
Eleven (2.6%) participants had a positive STI test result 
for two pathogens. The prevalence of C. trachomatis was 
26/275 (9.5%, 95% CI 6.3% to 13.5%) among women 
and 17/133 (12.8%, 95% CI 7.6% to 19.7%) among men. 
For N. gonorrhoeae, prevalence was 18/275 (6.5%, 95% CI 
3.6% to 10.1%) among women and 19/150 (12.7%, 95% 
CI 7.8% to 19.1%, p=0.032) among men. STIs were more 
common in those with recent symptom onset (52/225, 
23.1% among those with an onset of symptoms of ≤7 days, 
and 31/197, 15.7% for those with symptoms >7 days, 
p=0.057). Participants who tested positive for an STI were 
younger and were less likely to have HIV infection than 
those without an STI (table 2).
The median duration of symptoms was 7 days for partic-
ipants with positive urine cultures and those who had an 
STI. Among participants who did not have an STI or a 
positive urine culture, the median duration of symptoms 
was 8 days (IQR 5–12). The most common presenting 
symptoms were dysuria (337/425, 79.3%), frequency 
(310/425, 72.9%) and suprapubic pain (272/425, 
64.0%). Overall presenting symptoms were similar 
between individuals with STIs and UTIs and those with 
negative cultures (figure 2).
Antimicrobial treatment prior to clinic presentation 
was reported by 30 (7.1%), while the antibiotic bioassay 
was positive in 73 (17.4%) including 26 participants 
with HIV infection who were taking co- trimoxazole 
prophylaxis. Overall, 89 (20.9%) of the participants had 
either reported taking antibiotics or had a positive urine 
bioassay.
STI treatment was prescribed by the clinic nurses at the 
initial visit in 38 participants, of whom 20 (53%) had a 
positive STI test, while 63 (76%) of the 83 patients who 
had an STI were not prescribed STI treatment by the 
primary healthcare nurse.
A follow- up phone call was made with 393 (92.5%) of 
the participants. Most (334/393, 85.0%) reported that 
the symptoms had resolved or significantly improved 
since enrolment. Among the 59 participants whose symp-
toms did not improve or resolve, 15 had a positive urine 
culture and 6 had an STI, while 32 (54.2%) did not have 
any positive tests. Symptom resolution or improvement 
was reported by 70/76 (92.1%) participants with an STI, 
by 74/89 (83.1%) of those with a positive urine culture 
and by 127/159 (79.9%) with negative results in all tests. 
Among participants with positive urine cultures, symp-
toms improved or resolved in 65/69 (94.2%) of those 
Figure 1 Distribution of positive tests among study 
participants (170/425 samples; 40% were negative for all 
tests). STI, sexually transmitted infection.
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who reported having taken their prescribed treatment 
and in 9/20 (45%) of those who had not.
DISCUSSION
This study found that only one in five people presenting 
to primary care in Harare with UTI symptoms had a 
positive urine culture with a uropathogen explaining 
their presenting symptoms. There was a high prevalence 
of STIs and evidence of prior antimicrobial use among 
study participants as possible explanations for the low 
proportion of positive urine cultures. However, in 40% of 
patients, symptoms remained unexplained.
Only 20% of study participants had a positive urine 
culture, which is similar to findings from studies 
conducted in other sub- Saharan African countries where 
culture positivity was found to be 11% and 36% among 
outpatients.5 9 In contrast, studies conducted among 
women with cystitis in high- income countries, mostly from 
Europe and the Americas, report that 75%–80% of urine 
cultures reveal significant growth of uropathogens.2 10 11 
This may be explained by differences in access to health-
care, unregulated antibiotic use and prevalence of other 
conditions with similar symptoms between settings.5 12–14
In our study, the median time to presentation was 
7 days, while studies from high- income settings report a 
much shorter time between symptom onset and clinic 
presentation of 2–3 days.10 11 Thus, the lower yield of 
urine cultures in this study may be due to spontaneous 
resolution of infection because of the delays in accessing 
healthcare or self- treatment with antibiotics.15 This may 
particularly be the case in patients with leucocyturia 
where symptoms can be explained by residual inflamma-
tion. Dysuria and leucocyturia in the absence of positive 
urine cultures may be due to other causes such as urogen-
ital tuberculosis, schistosomiasis and other inflamma-
tory conditions.3 However, other infections are unlikely 
to be the cause of symptoms in our patient population, 
given that for the vast majority, the symptoms resolved or 
improved on follow- up and that haematuria was present 
in less than 1%.
Antimicrobial use prior to clinic presentation may 
also have contributed to a lower urine culture yield, with 





































































































































































































































































































































































































































































































































































Figure 2 Presenting symptoms in study participants 
according to urine culture and STI test result. Severe 
symptoms were defined as symptoms affecting daily 
activities. STI, sexually transmitted infection.
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antibiotics prior to presentation to primary care. While 
only 7% of the study participants reported antimicro-
bial use in the previous 2 weeks, 17% had evidence of 
antimicrobial activity in their urine. Although antibiotic 
access from pharmacies is highly regulated in Zimbabwe, 
antibiotics can be acquired from the informal market.16 
Patients may not report on self- treatment at clinic presen-
tation due to social desirability bias. Prior antimicro-
bial use was similar to that reported by patients from 
Senegal,17 which had a culture positivity of 27% but lower 
than that in studies from the USA.18 This suggests that 
asking patients about antimicrobials may not be sufficient 
in determining prior exposure as shown in findings from 
Ghana.19 On the other hand, the antibiotic bioassay may 
overestimate antimicrobial use for treatment of infec-
tions by also detecting antimicrobials consumed uninten-
tionally in food and water.20 Alternative explanations for 
symptoms suggestive of UTIs such as dysuria include irri-
tant hygienic products, spermicides and certain foods.3
STIs are highly prevalent in some sub- Saharan African 
settings,21 and there is some symptom overlap between 
STIs and UTIs. A meta- analysis of studies from sub- 
Saharan Africa reported a pooled prevalence for C. 
trachomatis of 7.8% in women of reproductive age,22 
while a study from Zimbabwe testing mainly asymptom-
atic adolescents and young people found a prevalence of 
17% of C. trachomatis and/or N. gonorrhoeae.23 While STIs 
may be asymptomatic particularly in women, patients 
with symptoms due to STIs frequently experience diag-
nostic and treatment delays leading to prolonged symp-
toms prior to presentation.24 One of the study eligibility 
criteria included recent symptom onset (within 2 weeks). 
This was aimed at increasing the likelihood of UTIs 
compared with STIs. Despite this, STI prevalence in our 
study was almost 20%. Importantly, 1 in 15 women and 
1 in 8 men tested positive for N. gonorrhoeae. The high 
prevalence of STIs may also explain the large propor-
tion of men enrolled into the study who are generally 
more likely to experience symptoms from STIs which 
are similar to symptoms of UTIs.24 The study may have 
missed other STIs because testing was limited to three 
major pathogens but did not include other organisms 
that may cause urethritis and urinary tract symptoms 
such as Mycoplasma genitalium, leading to an underesti-
mation of STI prevalence. Furthermore, STIs may have 
been missed because the study used mid- stream urine 
samples, while first- catch samples are recommended for 
the diagnosis of STIs for optimal yield on urine samples. 
Genital ulcers caused by herpes simplex and vaginitis due 
to Candida spp. may explain symptoms in some patients. 
Also, men were not tested for T. vaginalis as this is less 
frequent in men.25 Potential participants who did not 
seek care because of not being able to afford the clinic 
fees would have been missed.
Only a quarter of participants who tested positive for an 
STI underwent STI treatment on the initial clinic presen-
tation because the attending nurse did not suspect an 
STI. This highlights the difficulties in differentiating the 
two conditions on clinical grounds. Access to diagnostic 
testing at primary care level is thus urgently needed.
The prevalence of STIs is not generalisable to all 
primary healthcare attendees, as the participants were 
selected on the basis of STI/UTI symptoms.
CONCLUSIONS
This is the first study exploring the causes for negative 
urine cultures among adults presenting with UTI symp-
toms to primary care in a low- income setting. The find-
ings of this study highlight the high STI burden in this 
patient population. The overlap in symptoms in patients 
diagnosed with UTIs and STIs, respectively, results in 
underdiagnosis and undertreatment of STIs. Diagnostic 
testing is paramount to ensure appropriate treatment. 
Very few participants who had an STI received appro-
priate treatment on clinic presentation because STIs were 
not suspected, emphasising the missed opportunities for 
diagnosis and treatment. The high prevalence of prior 
antibiotic exposure in patients presenting to primary care 
should prompt an improvement of regulations around 
antibiotic access to prevent development of antimicrobial 
resistance.
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